CEO of Repligen Corp (30-Year Financial, Insider Trades) Anthony Hunt (insider trades) sold 45,351 shares of RGEN on 09/10/2020 at an average price of $148.2 a share. The total sale was $6.7 million.
Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen Corp has a market cap of $7.6 billion; its shares were traded at around $144.66 with a P/E ratio of 249.41 and P/S ratio of 25.27. Repligen Corp had annual average EBITDA growth of 19.90% over the past five years. GuruFocus has detected 2 severe warning signs with Repligen Corp. .
CEO Recent Trades:
- CEO Anthony Hunt sold 45,351 shares of RGEN stock on 09/10/2020 at the average price of $148.2. The price of the stock has decreased by 2.39% since.
For the complete insider trading history of RGEN, click here
.This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
